Expertise in
27
conditions

Dr. Jaishri Blakeley

Neurology
Johns Hopkins University
601 N Caroline St, 
Baltimore, MD 
Offers Telehealth
Expertise in
27
conditions
Johns Hopkins University
601 N Caroline St, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jaishri Blakeley is a Neurologist in Baltimore, Maryland. Dr. Blakeley is highly rated in 27 conditions, according to our data. Their top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.

Their clinical research consists of co-authoring 175 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in MD
Hospital Affiliations
The Johns Hopkins Hospital
Languages Spoken
English

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

JOHNS HOPKINS UNIVERSITY
601 N Caroline St, Baltimore, MD 21287
Other Locations
JOHNS HOPKINS UNIVERSITY
600 N Wolf St, Baltimore, MD 21287

Additional Areas of Focus

Dr. Blakeley has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Enrollment Status: Active_not_recruiting
Publish Date: November 18, 2024
Intervention Type: Drug
Study Drug: Brigatinib
Study Phase: Phase 2
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Phase 2 Dose-Response Study to Determine Safety and Effectiveness of Two Concentrations of NFX-179 Gel in Subjects With Cutaneous Neurofibromas
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Drug
Study Drug: NFX-179
Study Phase: Phase 2
A Phase II Trial of Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Salvage Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma Multiforme
A Phase II Trial of Low Dose Fractionated Radiation Therapy as a Chemo-Potentiator of Salvage Temozolomide for Recurrent Anaplastic Astrocytoma and Glioblastoma Multiforme
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Drug
Study Drug: Cabozantinib
Study Phase: Phase 2
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Open-label, Phase 2 Study of Bevacizumab in Children and Young Adults With Neurofibromatosis 2 and Progressive Vestibular Schwannomas That Are Poor Candidates for Standard Treatment With Surgery or Radiation
Enrollment Status: Completed
Publish Date: February 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas
Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas
Enrollment Status: Completed
Publish Date: January 12, 2021
Intervention Type: Drug
Study Phase: Early Phase 1
View 5 Less Clinical Trials

174 Total Publications

Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib.
Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib.
Journal: Neuro-oncology
Published: October 10, 2024
Similar Doctors
Expertise in
42
conditions
Dr. Alexander Y. Pantelyat
Neurology
Expertise in
42
conditions
Dr. Alexander Y. Pantelyat
Neurology

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (0.2 mi)
410-955-5000
Languages Spoken:
English, Russian, Spanish
See accepted insurances
Accepting New Patients

Alexander Pantelyat is a Neurologist in Baltimore, Maryland. Dr. Pantelyat is highly rated in 42 conditions, according to our data. His top areas of expertise are Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration. Dr. Pantelyat is currently accepting new patients.

Expertise in
15
conditions
Dr. Scott D. Newsome
Neurology
Expertise in
15
conditions
Dr. Scott D. Newsome
Neurology

Johns Hopkins University

600 N Wolf St, 
Baltimore, MD 
 (0.2 mi)
410-955-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Newsome is a Neurologist in Baltimore, Maryland. Dr. Newsome is highly rated in 15 conditions, according to our data. His top areas of expertise are Stiff Person Syndrome, Multiple Sclerosis (MS), Transverse Myelitis, and Relapsing Multiple Sclerosis (RMS). Dr. Newsome is currently accepting new patients.

Andrew L. Mammen
Expertise in
10
conditions
Dr. Andrew L. Mammen
Neurology
Expertise in
10
conditions
Dr. Andrew L. Mammen
Neurology
4940 Eastern Ave, 
Baltimore, MD 
 (2.6 mi)
410-550-5624
Languages Spoken:
English

Andrew Mammen is a Neurologist in Baltimore, Maryland. Dr. Mammen is highly rated in 10 conditions, according to our data. His top areas of expertise are Myositis, Dermatomyositis, Polymyositis, and Necrotizing Myopathy (NM).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Blakeley's expertise for a condition
ConditionClose
View All 14 Distinguished Conditions
View All 8 Advanced Conditions
View All 17 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile